Medical News

RSS

NIAID awards Pulmatrix $2.2M grant for developing novel influenza therapeutics

Pulmatrix, a clinical stage biotechnology company discovering and developing a new class of therapies for the treatment and prevention of infectious and progressive respiratory diseases, today announced that it has been awarded a grant for $2.2 million from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), aimed at advancing the development of novel influenza therapeutics for the treatment of seasonal and pandemic influenza.

2 Nov 2009

Pulmatrix raises $30.2 million through Series B financing

Pulmatrix, a clinical stage biotechnology company discovering and developing a new class of therapies for the treatment and prevention of infectious and progressive respiratory diseases, today announced that it has secured $30.2 million in Series B financing. ARCH Venture Partners and Novartis Bioventures Fund co-led the round with participation from existing investors Polaris Venture Partners and 5AM Ventures.

2 Nov 2009

First human robot assisted aortic valve replacement to implant the ATS 3f Aortic Bioprosthesis performed

ATS Medical, Inc., manufacturer and marketer of state-of-the-art cardiac surgery products and services, announced the first human robot assisted endoscopic aortic valve replacement using the daVinci® Surgical System from Intuitive Surgical to implant the ATS 3f® Aortic Bioprosthesis. The procedure was performed by Allen Raczkowski, M.D., at Banner Baywood Health Hospital in Phoenix, Arizona.

2 Nov 2009

Deep brain stimulation can help patients with severe forms of depression

In deep brain stimulation, doctors specifically target the impaired function of certain areas of the brain with an electric brain pacemaker. For the purpose of this study, they implanted electrodes in what is known as the nucleus accumbens. That is an important part of the 'reward system' which ensures that we remember good experiences and puts us in a state of pleasant anticipation.

2 Nov 2009

MTD Products and AHA team up to promote heart health and winter safety

What do sipping cocoa, snuggling under blankets and heart attacks all have in common? They are all more common during the cold winter months.

2 Nov 2009

Virtual world solution to address the unique needs of military amputees

Virtual worlds can provide military amputees with an opportunity to enhance their overall quality of life, expedite their reintegration into society, and improve their physical and mental wellness.

2 Nov 2009

Optics industry reinventing itself through personalized service logistics solutions

GfK Asia releases its Pan Asia optical retailers and consumers preference survey information in line with the 17th Hong Kong Optical Fair, hosted by Hong Kong Trade Development Council. The five key regions surveyed in October 2009 include China, Hong Kong, Korea, Singapore and Malaysia. The survey shows that 70% of optical retailers indicate business will be better or the same in 2010.

2 Nov 2009

Medela to host Virtual Human Milk Collection Campaign

Medela today announced it will host a Virtual Human Milk (breastmilk) Collection Campaign in honor of the March of Dimes' National Prematurity Awareness Month and the thousands of dedicated Neonatal healthcare professionals nationwide.

2 Nov 2009

Metro Dentalcare sponsors Halloween candy buyback event

Halloween candy is a sweet treat for kids and a nightmare for parents, but this Halloween, kids can turn their goodies into cash and donations for charities. Thirteen Metro Dentalcare locations around the Twin Cities are sponsoring Halloween candy buybacks on Nov. 2.

2 Nov 2009

Canadian programs underscore evidence of PEGETRON's positive outcomes in treating HCV infection

Results from two significant Canadian studies underscore the growing scientific evidence of PEGETRON's positive outcomes in the treatment of chronic hepatitis C virus (HCV) infection. Canadian investigators across the country collaborated to generate and analyze clinical data from the Canadian PEGETRON POWeR (Prospective Optimal Weight-based Dosing Response) and REDIPEN programs, which were presented at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting in Boston on November 1, 2009.

2 Nov 2009

Music super stars unite to launch campaign for bone marrow donation

United under a same mission, music super stars, Placido Domingo, Gloria Estefan, David Bisbal, Luis Fonsi, Arthur Hanlon, Wisin & Yandel and Enrique Iglesias amongst other Latin music stars, will become ambassadors of hope through this historic initiative; "Unete Con La Gota de la Vida, Benefiting City of Hope."

2 Nov 2009

Methacetin breath test predicts long-term survival in patients with chronic viral hepatitis

A methacetin breath test (MBT) that can be performed quickly and noninvasively has been proven to accurately predict survival in patients with viral hepatitis and may be used as an adjunctive tool to MELD.

2 Nov 2009

MEDNAX announces financial results for the third quarter of 2009

MEDNAX, Inc. today reported record results from operations for the three months and nine months ended September 30, 2009, that reflect contributions from acquisitions, same-unit revenue growth and operating efficiencies.

2 Nov 2009

Humana reports higher consolidated revenues for third quarter at $7.72 billion

Humana Inc. today reported diluted earnings per common share (EPS) for the quarter ended September 30, 2009 (3Q09) of $1.78, consistent with management’s guidance of $1.75 to $1.80. The company earned $1.09 per share for the quarter ended September 30, 2008 (3Q08) which reflected $0.40 per share in realized losses primarily associated with other-than-temporary impairments in investments and sales of distressed financial institution securities.

2 Nov 2009

New Aplio MX ultrasound system from Toshiba

Hospitals use ultrasound as a first-line diagnostic exam, requiring them to have cutting-edge ultrasound technology available to quickly and efficiently perform a range of patient exams. To meet these demanding clinical needs, while also considering the financial challenges facing many hospitals today, Toshiba America Medical Systems, Inc. has introduced the AplioTM MX ultrasound system, a compact system that offers premium clinical performance and high-end features at an affordable price point.

2 Nov 2009

Rap video teaches kids how to avoid getting swine flu

"Blah, blah, H1N1 blah," is what many kids hear when their parents try to teach them how to avoid getting H1N1, or the swine flu. To cut through the blahs let DocRock and his H1N1 Rap teach your kids how to avoid catching H1N1 or the regular seasonal flu.

2 Nov 2009

Nuevolution receives milestone payment from Merck

Nuevolution A/S today announced that it has received a milestone payment derived from its collaboration with Merck & Co. Inc., Whitehouse Station, NJ.

2 Nov 2009

Dietary cholesterol is not a primary factor for coronary heart disease

Contrary to the established view, current data suggest that dietary cholesterol is not a primary factor of or causes heart disease - with the possible exception of the genetic forms of familial hypercholesterolemias. For instance, recent clinical trials evaluating the effect of cholesterol-lowering drugs on the development of chronic heart failure, diabetes and stroke have yielded disappointing results.

2 Nov 2009

ACM Global Central Laboratory celebrates landmark anniversary

ACM Global Central Laboratory, the global central lab that continually defines the customer-service standard with its flexible approach, is this week celebrating its 10th anniversary of providing central laboratory services throughout Europe.

2 Nov 2009

NOXXON Pharma commences human dosing in Spiegelmer NOX-A12 clinical trial

NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, announced today the successful initial dosing of healthy volunteers in a first-in-human clinical trial with Spiegelmer® NOX-A12. NOX-A12 is NOXXON’s second drug candidate entering the clinical stage of development within only five months.

2 Nov 2009